Effect of Growth Hormone Administration: Reciprocal Changes in Serum lα,25-Dihydroxyvitamin D and Intestinal Calcium Absorption*

The mechanism by which GH stimulates intestinal calcium absorption was explored. In this study, seven children with idiopathic GH deficiency were studied before and during GH therapy while they were maintained on the same metabolic diet. After 5–14 months of GH administration, fractional intestinal calcium absorption increased from 0.364 ± 0.114 to 0.449 ± 0.159 (P < 0.01), and serum 1,25-dihydroxyvitamin D decreased from 63.7 ± 19.3 to 46.7 ± 17.8 pg/ml (P < 0.025). Serum immunoreactive parathyroid hormone, urinary cAMP, serum 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D did not change significantly.The data suggest that GH does not directly influence parathyroid hormone or vitamin D metabolism. The possibility that relative intestinal resistance to 1,25-dihydroxyvitaminD exists in patients with GH deficiency is considered. (J Clin Endocrinol Metab 51: 321, 1980)

[1]  A. Norman,et al.  Acromegaly and vitamin D metabolism: effect of bromocriptine treatment. , 1979, The Journal of clinical endocrinology and metabolism.

[2]  H. Rasmussen,et al.  Parathyroid function and vitamin D metabolism during human growth hormone replacement. , 1979, The Journal of clinical endocrinology and metabolism.

[3]  C. Pak,et al.  Evaluation of calcium urolithiasis in ambulatory patients: comparison of results with those of inpatient evaluation. , 1978, The American journal of medicine.

[4]  M. Haussler,et al.  Effect of growth hormone on vitamin D metabolism , 1978, Nature.

[5]  H. DeLuca,et al.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. , 1976, Archives of biochemistry and biophysics.

[6]  G. Hargis,et al.  The effect of growth hormone on parathyroid function in rats. , 1976, Endocrinology.

[7]  W. Clarke,et al.  Evaluation of growth hormone release in children using arginine and L-dopa in combination. , 1975, The Journal of pediatrics.

[8]  C. Pak,et al.  The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. , 1974, The Journal of clinical investigation.

[9]  D. Lawson,et al.  Competitive protein-binding assay for 25-hydroxycholecalciferol. , 1974, Clinical science and molecular medicine.

[10]  J. V. Van Wyk,et al.  Growth hormone levels during sleep in normal and growth hormone deficient children. , 1971, Pediatrics.

[11]  A. Gilman.  A protein binding assay for adenosine 3':5'-cyclic monophosphate. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Frasier,et al.  The serum growth-hormone response to hypoglycemia in dwarfism. , 1967, The Journal of pediatrics.

[13]  P. Henneman,et al.  Effects of human growth hormone in man. , 1960, The Journal of clinical investigation.

[14]  C. Arnaud,et al.  Radioimmunoassay of human parathyroid hormone in serum. , 1971, The Journal of clinical investigation.